Guizhounli Pharmaceutical Co (SHSE:603439) 3-Year EBITDA Growth Rate : 43.60% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Guizhounli Pharmaceutical Co 3-Year EBITDA Growth Rate?

Guizhounli Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.18.

During the past 12 months, Guizhounli Pharmaceutical Co's average EBITDA Per Share Growth Rate was 25.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 43.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 17.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Guizhounli Pharmaceutical Co was 43.60% per year. The lowest was 5.60% per year. And the median was 13.65% per year.

Competitive Comparison of Guizhounli Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Guizhounli Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guizhounli Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guizhounli Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Guizhounli Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Guizhounli Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Guizhounli Pharmaceutical Co (SHSE:603439) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Guizhounli Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Guizhounli Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhounli Pharmaceutical Co (SHSE:603439) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000

Website

http://www.gz-sanli.com

Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.

Executives

Zhang Hong Yu	Directors, senior managers
Wang Yi	senior management
Zhang Qian Fan	Directors, senior managers
Sheng Yong Jian	Director

Guizhounli Pharmaceutical Co (SHSE:603439) Headlines

No Headlines